nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—NR1H4—bile—Crohn's disease	0.183	0.436	CbGeAlD
Fulvestrant—NR1H4—gall bladder—Crohn's disease	0.0509	0.121	CbGeAlD
Fulvestrant—NR1H4—digestive system—Crohn's disease	0.02	0.0476	CbGeAlD
Fulvestrant—EPHX2—mammalian vulva—Crohn's disease	0.0199	0.0474	CbGeAlD
Fulvestrant—ESRRA—Preimplantation Embryo—SOX11—Crohn's disease	0.0185	0.119	CbGpPWpGaD
Fulvestrant—ESRRA—mammalian vulva—Crohn's disease	0.0175	0.0415	CbGeAlD
Fulvestrant—ESRRA—digestive system—Crohn's disease	0.0153	0.0364	CbGeAlD
Fulvestrant—ESR2—epithelium—Crohn's disease	0.0121	0.0287	CbGeAlD
Fulvestrant—Vaginal moniliasis—Mesalazine—Crohn's disease	0.012	0.0283	CcSEcCtD
Fulvestrant—ESR2—smooth muscle tissue—Crohn's disease	0.0116	0.0277	CbGeAlD
Fulvestrant—Vulvovaginal candidiasis—Mesalazine—Crohn's disease	0.0115	0.0272	CcSEcCtD
Fulvestrant—NR1H4—lymph node—Crohn's disease	0.0114	0.0272	CbGeAlD
Fulvestrant—Vulvovaginal mycotic infection—Mesalazine—Crohn's disease	0.0111	0.0261	CcSEcCtD
Fulvestrant—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.0103	0.0243	CcSEcCtD
Fulvestrant—EPHX2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.01	0.0641	CbGpPWpGaD
Fulvestrant—EPHX2—lymph node—Crohn's disease	0.00999	0.0238	CbGeAlD
Fulvestrant—ESR2—lymphoid tissue—Crohn's disease	0.00931	0.0221	CbGeAlD
Fulvestrant—ESR2—digestive system—Crohn's disease	0.0092	0.0219	CbGeAlD
Fulvestrant—ESRRA—lymph node—Crohn's disease	0.00875	0.0208	CbGeAlD
Fulvestrant—ESR1—epithelium—Crohn's disease	0.00828	0.0197	CbGeAlD
Fulvestrant—ESR1—smooth muscle tissue—Crohn's disease	0.00798	0.019	CbGeAlD
Fulvestrant—Gamma-glutamyltransferase increased—Mesalazine—Crohn's disease	0.00736	0.0174	CcSEcCtD
Fulvestrant—Breast disorder—Mercaptopurine—Crohn's disease	0.00731	0.0173	CcSEcCtD
Fulvestrant—Vasodilation procedure—Mesalazine—Crohn's disease	0.00689	0.0163	CcSEcCtD
Fulvestrant—Vasodilation—Mesalazine—Crohn's disease	0.00689	0.0163	CcSEcCtD
Fulvestrant—Cough increased—Mesalazine—Crohn's disease	0.00661	0.0156	CcSEcCtD
Fulvestrant—Hepatic enzyme increased—Mesalazine—Crohn's disease	0.0064	0.0151	CcSEcCtD
Fulvestrant—Blood bilirubin increased—Mesalazine—Crohn's disease	0.0064	0.0151	CcSEcCtD
Fulvestrant—ESR1—lymphoid tissue—Crohn's disease	0.00638	0.0152	CbGeAlD
Fulvestrant—Embolism venous—Prednisone—Crohn's disease	0.00635	0.015	CcSEcCtD
Fulvestrant—ESR1—digestive system—Crohn's disease	0.0063	0.015	CbGeAlD
Fulvestrant—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00613	0.0145	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0059	0.0139	CcSEcCtD
Fulvestrant—Hepatic failure—Azathioprine—Crohn's disease	0.00537	0.0127	CcSEcCtD
Fulvestrant—ESR2—lymph node—Crohn's disease	0.00525	0.0125	CbGeAlD
Fulvestrant—Immune system disorder—Mercaptopurine—Crohn's disease	0.00506	0.0119	CcSEcCtD
Fulvestrant—Hepatic failure—Mesalazine—Crohn's disease	0.00489	0.0115	CcSEcCtD
Fulvestrant—Malnutrition—Mercaptopurine—Crohn's disease	0.00487	0.0115	CcSEcCtD
Fulvestrant—ESRRA—PPARA activates gene expression—FADS1—Crohn's disease	0.00454	0.0291	CbGpPWpGaD
Fulvestrant—Arthritis—Mesalazine—Crohn's disease	0.00452	0.0107	CcSEcCtD
Fulvestrant—Anaemia—Mercaptopurine—Crohn's disease	0.00451	0.0106	CcSEcCtD
Fulvestrant—NR1H4—Recycling of bile acids and salts—ALB—Crohn's disease	0.00447	0.0287	CbGpPWpGaD
Fulvestrant—ESRRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.00445	0.0285	CbGpPWpGaD
Fulvestrant—Leukopenia—Mercaptopurine—Crohn's disease	0.00436	0.0103	CcSEcCtD
Fulvestrant—Arthralgia—Mercaptopurine—Crohn's disease	0.00415	0.0098	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00412	0.00973	CcSEcCtD
Fulvestrant—Breast disorder—Mesalazine—Crohn's disease	0.00397	0.00937	CcSEcCtD
Fulvestrant—Skin disorder—Mercaptopurine—Crohn's disease	0.00386	0.00912	CcSEcCtD
Fulvestrant—Influenza—Mesalazine—Crohn's disease	0.0038	0.00896	CcSEcCtD
Fulvestrant—Anorexia—Mercaptopurine—Crohn's disease	0.00379	0.00895	CcSEcCtD
Fulvestrant—Infestation NOS—Azathioprine—Crohn's disease	0.00372	0.00877	CcSEcCtD
Fulvestrant—Infestation—Azathioprine—Crohn's disease	0.00372	0.00877	CcSEcCtD
Fulvestrant—EPHX2—Metapathway biotransformation—GPX4—Crohn's disease	0.00367	0.0235	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00362	0.00856	CcSEcCtD
Fulvestrant—ESR1—lymph node—Crohn's disease	0.0036	0.00855	CbGeAlD
Fulvestrant—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00352	0.0083	CcSEcCtD
Fulvestrant—CYP3A4—digestive system—Crohn's disease	0.00351	0.00836	CbGeAlD
Fulvestrant—Decreased appetite—Mercaptopurine—Crohn's disease	0.00346	0.00816	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00343	0.00811	CcSEcCtD
Fulvestrant—Infestation NOS—Mesalazine—Crohn's disease	0.00339	0.00799	CcSEcCtD
Fulvestrant—Infestation—Mesalazine—Crohn's disease	0.00339	0.00799	CcSEcCtD
Fulvestrant—Depression—Mesalazine—Crohn's disease	0.00338	0.00797	CcSEcCtD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL23A—Crohn's disease	0.00337	0.0216	CbGpPWpGaD
Fulvestrant—Haemoglobin—Azathioprine—Crohn's disease	0.00335	0.00792	CcSEcCtD
Fulvestrant—ESR2—Ovarian Infertility Genes—SMAD3—Crohn's disease	0.00334	0.0214	CbGpPWpGaD
Fulvestrant—Haemorrhage—Azathioprine—Crohn's disease	0.00334	0.00788	CcSEcCtD
Fulvestrant—NR1H4—PPARA activates gene expression—FADS1—Crohn's disease	0.00332	0.0213	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CREM—Crohn's disease	0.0033	0.0212	CbGpPWpGaD
Fulvestrant—Urinary tract infection—Mesalazine—Crohn's disease	0.00329	0.00777	CcSEcCtD
Fulvestrant—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—FADS1—Crohn's disease	0.00325	0.0208	CbGpPWpGaD
Fulvestrant—Sweating—Mesalazine—Crohn's disease	0.00325	0.00766	CcSEcCtD
Fulvestrant—Hepatobiliary disease—Mesalazine—Crohn's disease	0.0032	0.00756	CcSEcCtD
Fulvestrant—Body temperature increased—Mercaptopurine—Crohn's disease	0.00314	0.00742	CcSEcCtD
Fulvestrant—ESRRA—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.00306	0.0197	CbGpPWpGaD
Fulvestrant—Haemoglobin—Mesalazine—Crohn's disease	0.00305	0.00721	CcSEcCtD
Fulvestrant—Haemorrhage—Mesalazine—Crohn's disease	0.00304	0.00718	CcSEcCtD
Fulvestrant—Hepatitis—Mesalazine—Crohn's disease	0.00304	0.00718	CcSEcCtD
Fulvestrant—Pharyngitis—Mesalazine—Crohn's disease	0.00302	0.00712	CcSEcCtD
Fulvestrant—Immune system disorder—Azathioprine—Crohn's disease	0.00301	0.00711	CcSEcCtD
Fulvestrant—Oedema peripheral—Mesalazine—Crohn's disease	0.00299	0.00707	CcSEcCtD
Fulvestrant—Connective tissue disorder—Mesalazine—Crohn's disease	0.00299	0.00705	CcSEcCtD
Fulvestrant—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00293	0.00692	CcSEcCtD
Fulvestrant—Angiopathy—Mesalazine—Crohn's disease	0.00276	0.00651	CcSEcCtD
Fulvestrant—Immune system disorder—Mesalazine—Crohn's disease	0.00275	0.00648	CcSEcCtD
Fulvestrant—Diarrhoea—Mercaptopurine—Crohn's disease	0.00272	0.00643	CcSEcCtD
Fulvestrant—EPHX2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00269	0.0173	CbGpPWpGaD
Fulvestrant—Anaemia—Azathioprine—Crohn's disease	0.00268	0.00634	CcSEcCtD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00261	0.0167	CbGpPWpGaD
Fulvestrant—Leukopenia—Azathioprine—Crohn's disease	0.0026	0.00614	CcSEcCtD
Fulvestrant—Back pain—Mesalazine—Crohn's disease	0.00256	0.00604	CcSEcCtD
Fulvestrant—Vomiting—Mercaptopurine—Crohn's disease	0.00253	0.00597	CcSEcCtD
Fulvestrant—Injury—Prednisone—Crohn's disease	0.00253	0.00597	CcSEcCtD
Fulvestrant—Rash—Mercaptopurine—Crohn's disease	0.00251	0.00592	CcSEcCtD
Fulvestrant—Dermatitis—Mercaptopurine—Crohn's disease	0.00251	0.00592	CcSEcCtD
Fulvestrant—Myalgia—Azathioprine—Crohn's disease	0.00247	0.00584	CcSEcCtD
Fulvestrant—Arthralgia—Azathioprine—Crohn's disease	0.00247	0.00584	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00246	0.0058	CcSEcCtD
Fulvestrant—Anaemia—Mesalazine—Crohn's disease	0.00245	0.00577	CcSEcCtD
Fulvestrant—Angioedema—Mesalazine—Crohn's disease	0.00242	0.00571	CcSEcCtD
Fulvestrant—Vertigo—Mesalazine—Crohn's disease	0.00238	0.00561	CcSEcCtD
Fulvestrant—Leukopenia—Mesalazine—Crohn's disease	0.00237	0.00559	CcSEcCtD
Fulvestrant—Nausea—Mercaptopurine—Crohn's disease	0.00236	0.00558	CcSEcCtD
Fulvestrant—Infection—Azathioprine—Crohn's disease	0.00235	0.00556	CcSEcCtD
Fulvestrant—NR1H4—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00234	0.015	CbGpPWpGaD
Fulvestrant—Cough—Mesalazine—Crohn's disease	0.00231	0.00545	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.0023	0.0148	CbGpPWpGaD
Fulvestrant—Skin disorder—Azathioprine—Crohn's disease	0.0023	0.00544	CcSEcCtD
Fulvestrant—ESR1—Nuclear signaling by ERBB4—RBX1—Crohn's disease	0.00229	0.0147	CbGpPWpGaD
Fulvestrant—Arthralgia—Mesalazine—Crohn's disease	0.00225	0.00532	CcSEcCtD
Fulvestrant—Myalgia—Mesalazine—Crohn's disease	0.00225	0.00532	CcSEcCtD
Fulvestrant—Chest pain—Mesalazine—Crohn's disease	0.00225	0.00532	CcSEcCtD
Fulvestrant—Anxiety—Mesalazine—Crohn's disease	0.00224	0.0053	CcSEcCtD
Fulvestrant—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—FADS1—Crohn's disease	0.00224	0.0144	CbGpPWpGaD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00224	0.00528	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00216	0.0051	CcSEcCtD
Fulvestrant—ESR1—FOXM1 transcription factor network—HSPA1B—Crohn's disease	0.00216	0.0138	CbGpPWpGaD
Fulvestrant—Infection—Mesalazine—Crohn's disease	0.00215	0.00506	CcSEcCtD
Fulvestrant—Nervous system disorder—Mesalazine—Crohn's disease	0.00212	0.005	CcSEcCtD
Fulvestrant—Skin disorder—Mesalazine—Crohn's disease	0.0021	0.00495	CcSEcCtD
Fulvestrant—Hyperhidrosis—Mesalazine—Crohn's disease	0.00209	0.00493	CcSEcCtD
Fulvestrant—Anorexia—Mesalazine—Crohn's disease	0.00206	0.00486	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00205	0.00483	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00197	0.00464	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00196	0.0126	CbGpPWpGaD
Fulvestrant—Insomnia—Mesalazine—Crohn's disease	0.00195	0.00461	CcSEcCtD
Fulvestrant—Paraesthesia—Mesalazine—Crohn's disease	0.00194	0.00458	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00194	0.00458	CcSEcCtD
Fulvestrant—Dyspnoea—Mesalazine—Crohn's disease	0.00193	0.00454	CcSEcCtD
Fulvestrant—Dyspepsia—Mesalazine—Crohn's disease	0.0019	0.00449	CcSEcCtD
Fulvestrant—Decreased appetite—Mesalazine—Crohn's disease	0.00188	0.00443	CcSEcCtD
Fulvestrant—Abdominal pain—Azathioprine—Crohn's disease	0.00187	0.00442	CcSEcCtD
Fulvestrant—Body temperature increased—Azathioprine—Crohn's disease	0.00187	0.00442	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00186	0.0044	CcSEcCtD
Fulvestrant—Fatigue—Mesalazine—Crohn's disease	0.00186	0.00439	CcSEcCtD
Fulvestrant—Constipation—Mesalazine—Crohn's disease	0.00185	0.00436	CcSEcCtD
Fulvestrant—Pain—Mesalazine—Crohn's disease	0.00185	0.00436	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00184	0.0118	CbGpPWpGaD
Fulvestrant—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—Crohn's disease	0.00179	0.0115	CbGpPWpGaD
Fulvestrant—Depression—Prednisone—Crohn's disease	0.00179	0.00422	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00177	0.00417	CcSEcCtD
Fulvestrant—Hypersensitivity—Azathioprine—Crohn's disease	0.00175	0.00412	CcSEcCtD
Fulvestrant—Urticaria—Mesalazine—Crohn's disease	0.00172	0.00405	CcSEcCtD
Fulvestrant—Abdominal pain—Mesalazine—Crohn's disease	0.00171	0.00403	CcSEcCtD
Fulvestrant—Body temperature increased—Mesalazine—Crohn's disease	0.00171	0.00403	CcSEcCtD
Fulvestrant—Diarrhoea—Azathioprine—Crohn's disease	0.00162	0.00383	CcSEcCtD
Fulvestrant—Haemoglobin—Prednisone—Crohn's disease	0.00162	0.00382	CcSEcCtD
Fulvestrant—Haemorrhage—Prednisone—Crohn's disease	0.00161	0.0038	CcSEcCtD
Fulvestrant—Hypersensitivity—Mesalazine—Crohn's disease	0.00159	0.00376	CcSEcCtD
Fulvestrant—ESR1—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.00158	0.0101	CbGpPWpGaD
Fulvestrant—Connective tissue disorder—Prednisone—Crohn's disease	0.00158	0.00373	CcSEcCtD
Fulvestrant—Dizziness—Azathioprine—Crohn's disease	0.00157	0.0037	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00157	0.01	CbGpPWpGaD
Fulvestrant—Asthenia—Mesalazine—Crohn's disease	0.00155	0.00366	CcSEcCtD
Fulvestrant—Pruritus—Mesalazine—Crohn's disease	0.00153	0.00361	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00153	0.00979	CbGpPWpGaD
Fulvestrant—Vomiting—Azathioprine—Crohn's disease	0.00151	0.00356	CcSEcCtD
Fulvestrant—Rash—Azathioprine—Crohn's disease	0.00149	0.00353	CcSEcCtD
Fulvestrant—Dermatitis—Azathioprine—Crohn's disease	0.00149	0.00353	CcSEcCtD
Fulvestrant—Headache—Azathioprine—Crohn's disease	0.00149	0.00351	CcSEcCtD
Fulvestrant—Diarrhoea—Mesalazine—Crohn's disease	0.00148	0.00349	CcSEcCtD
Fulvestrant—Angiopathy—Prednisone—Crohn's disease	0.00146	0.00344	CcSEcCtD
Fulvestrant—Immune system disorder—Prednisone—Crohn's disease	0.00145	0.00343	CcSEcCtD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00143	0.00917	CbGpPWpGaD
Fulvestrant—Dizziness—Mesalazine—Crohn's disease	0.00143	0.00337	CcSEcCtD
Fulvestrant—Nausea—Azathioprine—Crohn's disease	0.00141	0.00332	CcSEcCtD
Fulvestrant—Malnutrition—Prednisone—Crohn's disease	0.0014	0.0033	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—PTRF—Crohn's disease	0.00139	0.00893	CbGpPWpGaD
Fulvestrant—Vomiting—Mesalazine—Crohn's disease	0.00137	0.00324	CcSEcCtD
Fulvestrant—Rash—Mesalazine—Crohn's disease	0.00136	0.00321	CcSEcCtD
Fulvestrant—Dermatitis—Mesalazine—Crohn's disease	0.00136	0.00321	CcSEcCtD
Fulvestrant—Headache—Mesalazine—Crohn's disease	0.00135	0.00319	CcSEcCtD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—ZMIZ1—Crohn's disease	0.00135	0.00866	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.00135	0.00863	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.00132	0.00844	CbGpPWpGaD
Fulvestrant—Anaemia—Prednisone—Crohn's disease	0.00129	0.00305	CcSEcCtD
Fulvestrant—Nausea—Mesalazine—Crohn's disease	0.00128	0.00303	CcSEcCtD
Fulvestrant—Angioedema—Prednisone—Crohn's disease	0.00128	0.00302	CcSEcCtD
Fulvestrant—Vertigo—Prednisone—Crohn's disease	0.00126	0.00297	CcSEcCtD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.00122	0.00783	CbGpPWpGaD
Fulvestrant—Myalgia—Prednisone—Crohn's disease	0.00119	0.00281	CcSEcCtD
Fulvestrant—Arthralgia—Prednisone—Crohn's disease	0.00119	0.00281	CcSEcCtD
Fulvestrant—Anxiety—Prednisone—Crohn's disease	0.00119	0.0028	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00118	0.00279	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.00114	0.00734	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.00114	0.00733	CbGpPWpGaD
Fulvestrant—Infection—Prednisone—Crohn's disease	0.00113	0.00268	CcSEcCtD
Fulvestrant—Nervous system disorder—Prednisone—Crohn's disease	0.00112	0.00264	CcSEcCtD
Fulvestrant—Skin disorder—Prednisone—Crohn's disease	0.00111	0.00262	CcSEcCtD
Fulvestrant—Hyperhidrosis—Prednisone—Crohn's disease	0.0011	0.00261	CcSEcCtD
Fulvestrant—Anorexia—Prednisone—Crohn's disease	0.00109	0.00257	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00109	0.00698	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00109	0.00698	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.00106	0.00678	CbGpPWpGaD
Fulvestrant—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00104	0.00246	CcSEcCtD
Fulvestrant—Insomnia—Prednisone—Crohn's disease	0.00103	0.00244	CcSEcCtD
Fulvestrant—EPHX2—Metabolism—PLA2G4F—Crohn's disease	0.00103	0.00658	CbGpPWpGaD
Fulvestrant—Paraesthesia—Prednisone—Crohn's disease	0.00103	0.00242	CcSEcCtD
Fulvestrant—NR1H4—Gene Expression—PTRF—Crohn's disease	0.00102	0.00653	CbGpPWpGaD
Fulvestrant—Dyspepsia—Prednisone—Crohn's disease	0.00101	0.00237	CcSEcCtD
Fulvestrant—Decreased appetite—Prednisone—Crohn's disease	0.000993	0.00234	CcSEcCtD
Fulvestrant—Fatigue—Prednisone—Crohn's disease	0.000985	0.00233	CcSEcCtD
Fulvestrant—Constipation—Prednisone—Crohn's disease	0.000977	0.00231	CcSEcCtD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL10—Crohn's disease	0.000976	0.00626	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL10—Crohn's disease	0.000935	0.006	CbGpPWpGaD
Fulvestrant—Gastrointestinal pain—Prednisone—Crohn's disease	0.000934	0.00221	CcSEcCtD
Fulvestrant—ESR1—Regulation of Telomerase—SMAD3—Crohn's disease	0.000921	0.00591	CbGpPWpGaD
Fulvestrant—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Crohn's disease	0.000917	0.00589	CbGpPWpGaD
Fulvestrant—Urticaria—Prednisone—Crohn's disease	0.000908	0.00214	CcSEcCtD
Fulvestrant—Abdominal pain—Prednisone—Crohn's disease	0.000903	0.00213	CcSEcCtD
Fulvestrant—Body temperature increased—Prednisone—Crohn's disease	0.000903	0.00213	CcSEcCtD
Fulvestrant—ESR1—Nuclear signaling by ERBB4—JAK2—Crohn's disease	0.000894	0.00574	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000891	0.00572	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PTRF—Crohn's disease	0.000886	0.00568	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—MTMR3—Crohn's disease	0.000872	0.0056	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000872	0.0056	CbGpPWpGaD
Fulvestrant—Hypersensitivity—Prednisone—Crohn's disease	0.000842	0.00199	CcSEcCtD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000835	0.00536	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—ZFP36L1—Crohn's disease	0.000834	0.00535	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—Crohn's disease	0.000832	0.00534	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PLA2G4F—Crohn's disease	0.00082	0.00526	CbGpPWpGaD
Fulvestrant—Asthenia—Prednisone—Crohn's disease	0.00082	0.00194	CcSEcCtD
Fulvestrant—Pruritus—Prednisone—Crohn's disease	0.000808	0.00191	CcSEcCtD
Fulvestrant—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—Crohn's disease	0.000801	0.00514	CbGpPWpGaD
Fulvestrant—Diarrhoea—Prednisone—Crohn's disease	0.000782	0.00185	CcSEcCtD
Fulvestrant—ESR1—Signaling by ERBB4—RBX1—Crohn's disease	0.000771	0.00495	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000767	0.00492	CbGpPWpGaD
Fulvestrant—Dizziness—Prednisone—Crohn's disease	0.000755	0.00178	CcSEcCtD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000737	0.00473	CbGpPWpGaD
Fulvestrant—Vomiting—Prednisone—Crohn's disease	0.000726	0.00171	CcSEcCtD
Fulvestrant—Rash—Prednisone—Crohn's disease	0.00072	0.0017	CcSEcCtD
Fulvestrant—Dermatitis—Prednisone—Crohn's disease	0.00072	0.0017	CcSEcCtD
Fulvestrant—Headache—Prednisone—Crohn's disease	0.000716	0.00169	CcSEcCtD
Fulvestrant—ESRRA—Gene Expression—DNMT3A—Crohn's disease	0.000709	0.00455	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—MTMR3—Crohn's disease	0.000697	0.00447	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—FADS1—Crohn's disease	0.00068	0.00436	CbGpPWpGaD
Fulvestrant—Nausea—Prednisone—Crohn's disease	0.000679	0.0016	CcSEcCtD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000678	0.00435	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000637	0.00409	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GPX4—Crohn's disease	0.000636	0.00408	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IFNG—Crohn's disease	0.00063	0.00404	CbGpPWpGaD
Fulvestrant—ESRRA—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000624	0.004	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—GCKR—Crohn's disease	0.000615	0.00394	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—ZFP36L1—Crohn's disease	0.000609	0.00391	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—TAB1—Crohn's disease	0.000608	0.0039	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PLA2G4F—Crohn's disease	0.000599	0.00385	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—CXCL8—Crohn's disease	0.000586	0.00376	CbGpPWpGaD
Fulvestrant—ESR1—Regulation of Telomerase—IFNG—Crohn's disease	0.000563	0.00361	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.000555	0.00356	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IFNG—Crohn's disease	0.00055	0.00353	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—FADS1—Crohn's disease	0.000543	0.00349	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000534	0.00343	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	0.000533	0.00342	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—ZFP36L1—Crohn's disease	0.000531	0.0034	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—JAK2—Crohn's disease	0.00053	0.0034	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—DNMT3A—Crohn's disease	0.000518	0.00332	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000512	0.00329	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—CXCL8—Crohn's disease	0.000511	0.00328	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—MTMR3—Crohn's disease	0.00051	0.00327	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GPX4—Crohn's disease	0.000509	0.00326	CbGpPWpGaD
Fulvestrant—ESR1—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000498	0.00319	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—GCKR—Crohn's disease	0.000491	0.00315	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—HSPA1B—Crohn's disease	0.000479	0.00307	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000468	0.003	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—IL1B—Crohn's disease	0.000464	0.00298	CbGpPWpGaD
Fulvestrant—NR1H4—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000456	0.00293	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—DNMT3A—Crohn's disease	0.000451	0.00289	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PTRF—Crohn's disease	0.000447	0.00287	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000439	0.00282	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—UBE2D1—Crohn's disease	0.00042	0.00269	CbGpPWpGaD
Fulvestrant—ESR2—Generic Transcription Pathway—SMAD3—Crohn's disease	0.000397	0.00255	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—FADS1—Crohn's disease	0.000397	0.00255	CbGpPWpGaD
Fulvestrant—ESR1—Leptin signaling pathway—STAT3—Crohn's disease	0.000389	0.0025	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000384	0.00247	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GPX4—Crohn's disease	0.000372	0.00239	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000372	0.00238	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—GCKR—Crohn's disease	0.000359	0.0023	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000351	0.00225	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—HSPA1B—Crohn's disease	0.00035	0.00225	CbGpPWpGaD
Fulvestrant—ESR1—ATF-2 transcription factor network—IL6—Crohn's disease	0.000329	0.00211	CbGpPWpGaD
Fulvestrant—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000316	0.00203	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—TYK2—Crohn's disease	0.000316	0.00203	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000307	0.00197	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000307	0.00197	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—UBE2D1—Crohn's disease	0.000307	0.00197	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—HSPA1B—Crohn's disease	0.000305	0.00196	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—JAK2—Crohn's disease	0.000301	0.00193	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—SMAD3—Crohn's disease	0.0003	0.00193	CbGpPWpGaD
Fulvestrant—ESR2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.0003	0.00192	CbGpPWpGaD
Fulvestrant—ESR1—AP-1 transcription factor network—IL6—Crohn's disease	0.000287	0.00184	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—UBE2D1—Crohn's disease	0.00028	0.0018	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ZFP36L1—Crohn's disease	0.000268	0.00172	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—UBE2D1—Crohn's disease	0.000267	0.00171	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	0.000257	0.00165	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ACKR2—Crohn's disease	0.000254	0.00163	CbGpPWpGaD
Fulvestrant—NR1H4—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000244	0.00157	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MLN—Crohn's disease	0.000241	0.00154	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	0.000236	0.00151	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—DNMT3A—Crohn's disease	0.000227	0.00146	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	0.000224	0.00144	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TAGAP—Crohn's disease	0.00022	0.00141	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SMAD3—Crohn's disease	0.00022	0.00141	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SMAD3—Crohn's disease	0.0002	0.00128	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—ALB—Crohn's disease	0.000196	0.00125	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RSPO3—Crohn's disease	0.000192	0.00123	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SMAD3—Crohn's disease	0.000191	0.00123	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SEL1L—Crohn's disease	0.000182	0.00117	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PTGS2—Crohn's disease	0.000171	0.0011	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR9—Crohn's disease	0.000167	0.00107	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	0.000159	0.00102	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—ALB—Crohn's disease	0.000156	0.001	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GPR65—Crohn's disease	0.000155	0.000995	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—IL6—Crohn's disease	0.000154	0.000991	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA1B—Crohn's disease	0.000154	0.000986	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—Crohn's disease	0.000137	0.000878	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—UBE2D1—Crohn's disease	0.000135	0.000865	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—Crohn's disease	0.000114	0.000733	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR6—Crohn's disease	0.00011	0.000709	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—Crohn's disease	0.0001	0.000641	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RBX1—Crohn's disease	9.99e-05	0.000641	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PTGER4—Crohn's disease	9.73e-05	0.000624	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SMAD3—Crohn's disease	9.64e-05	0.000618	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—UBE2D1—Crohn's disease	8.76e-05	0.000562	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	8.58e-05	0.00055	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RIPK2—Crohn's disease	8.5e-05	0.000545	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL3—Crohn's disease	8.28e-05	0.000532	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RASGRP1—Crohn's disease	8.01e-05	0.000514	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTMR3—Crohn's disease	7.29e-05	0.000468	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS1—Crohn's disease	7.26e-05	0.000466	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SMAD3—Crohn's disease	6.27e-05	0.000402	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL2RA—Crohn's disease	5.8e-05	0.000372	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—FADS1—Crohn's disease	5.68e-05	0.000365	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX4—Crohn's disease	5.32e-05	0.000341	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCKR—Crohn's disease	5.14e-05	0.00033	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TYK2—Crohn's disease	4.09e-05	0.000262	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAK2—Crohn's disease	3.9e-05	0.00025	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—Crohn's disease	3.56e-05	0.000228	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT3—Crohn's disease	2.86e-05	0.000184	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—Crohn's disease	2e-05	0.000128	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—Crohn's disease	1.64e-05	0.000105	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.43e-05	9.18e-05	CbGpPWpGaD
